Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
about
New target for inhibition of bacterial RNA polymerase: 'switch region'Evolution of MRSA during hospital transmission and intercontinental spreadMolecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, SpainNew mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitalsMolecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China.In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureusGenetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease.Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.Poly(trimethylene carbonate) as a carrier for rifampicin and vancomycin to target therapy-recalcitrant staphylococcal biofilms.Rifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureusFitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.Resistance to rifampicin: a review.Evolution toward small molecule inhibitor resistance affects native enzyme function and stability, generating acarbose-insensitive cyclodextrin glucanotransferase variants.Rifamycins, Alone and in Combination.Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.Testing the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance.Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.
P2860
Q24634933-6C6ED476-EC0F-481E-8979-ACE5C0FE9D1CQ29615141-3BA633B7-812F-4998-AA75-F50CBAF53BFAQ33536820-D162D260-9E2A-49FE-97B7-D5A693071468Q33836747-77889EDC-C76E-4839-9F52-B3B77754C0B0Q34452505-F1F76747-2B99-414F-BBCF-CE37851C2EF3Q34509698-F64D50AD-2CE1-4051-B2B5-61732182F194Q34680589-E22391D5-1A07-4ED0-A66A-DF0C1506072DQ34933382-6E743F42-2658-44F3-9191-60E008EDBA1AQ35690337-E2AEA979-07AD-412D-9B71-1924F652D109Q35746096-499BEC59-E0FA-433C-90E5-E26785301981Q35923715-28556B03-445B-4F77-B572-BB7AD3D7E953Q36081351-9E61AC21-F520-4977-ABFF-1BF333B06BB2Q36290567-508272E0-8EDD-4905-A02A-F0420FED1BA7Q36787486-958E307C-B0D1-4776-B58E-DF66E6366E8CQ36804040-EC82C8FA-09A5-4B0C-BB55-B74925E6A1D4Q37379658-0F0181A6-D5FD-4193-8143-963B07AD6029Q37671492-80BEE500-5218-4EAE-BA8C-78A4FD897E94Q38239459-A9CF208D-0AB9-49E5-912A-917ADE8C807EQ38293433-E0BCDCFC-D62F-4452-A3AE-106C250206CCQ38857578-61BD2F88-FD60-4315-B04C-D8D213922778Q40572948-7F9E017F-494E-4FE2-AFAF-7D7A2A6AB543Q41184787-16BED7AE-F43A-4FCA-82D1-4F50D6640DD9Q41808347-080BED45-E6A5-4011-BC3A-FC30B51A5CCBQ41846993-3C576F2A-A2AC-46B2-8902-A7B85DF9EC20Q41851810-B2F0A2A9-22EF-4444-974A-4B2A9DF05117Q42708789-1D9E9668-B3ED-4564-B87B-B543EDD8F212Q53780871-06AD9C2C-01DF-4628-AEEB-86F4AE3DA339
P2860
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@ast
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@en
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@nl
type
label
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@ast
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@en
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@nl
prefLabel
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@ast
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@en
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@nl
P2093
P2860
P3181
P1476
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus
@en
P2093
Albrecht Ludwig
Boris Böddinghaus
Silke Besier
Thomas A Wichelhaus
Volker Brade
Volker Schäfer
P2860
P304
P3181
P356
10.1128/AAC.46.11.3381-3385.2002
P407
P577
2002-11-01T00:00:00Z